Early-onset #CRC has become one of the most unsettling epidemiologic shifts in gastrointestinal oncology.
Explore the molecular and microbiome-associated mechanisms, screening limitations, treatment considerations, and more.

Early-onset #CRC has become one of the most unsettling epidemiologic shifts in gastrointestinal oncology.
Explore the molecular and microbiome-associated mechanisms, screening limitations, treatment considerations, and more.
Deadline extended! Know an "unsung hero" in cancer clinical trials research? 🩺✨
Nominations are open for the 2026 Richard L. Schilsky CALGB Achievement Award! Help Alliance for Clinical Trials in Oncology honor those making a difference!
🗓️ Deadline: Sept 11 🔗 https://bit.ly/Schilsky26 #oncsky
Alliance for Clinical Trials in Oncology trial enrolling! Dr. Gabe Brooks of Dartmouth Cancer leads the PAGODA trial (A232402CD) aimed at reducing unplanned treatment delays in people with gastrointestinal cancers. Learn more at https://bit.ly/PAGODA26. #ColorectalCancer #OncSky #ClinicalTrials
The Oct 2026 issue of @LancetGastroHep is out today! www.thelancet.com/gastrohep
Content includes: #colorectalcancer, #MASLD, #viralhepatitis, #DGBI, #LynchSyndrome, bowel #endometriosis + more!